A new study compared medical care cost estimates of different cancer types for patients aged at least 18 years and provided important evidence about the cost of cancer care across the age spectrum.
Referral of newly diagnosed adolescent patients with acute lymphoblastic leukemia to pediatric and National Cancer Institute-designated centers should be strongly recommended.
In comparison to the funding and survival rate of many other cancer types, funding for ovarian, cervical, and uterine cancer does not align with their survival rates.
Participation in clinical trials may help overcome health disparities in the treatment of advanced or recurrent ovarian cancer, according to a presentation at the SGO 2018 Annual Meeting on Women’s Cancer.
A session highlighted strategies for managing clinical trials for cancer and improving patient accrual in the community setting.
Socioeconomic inequalities may affect cancer-specific survival and overall survival in patients with squamous cell carcinoma of the anus.
Research presented at the 2018 BMT Tandem Meetings showed that potential role of immune checkpoint inhibitors in the post-transplant setting for patients with relapsed or large B-cell lymphomas.
A study to be presented at the BMT Tandem Meetings found no difference in OS for patients aged 55-64 years compared with those aged 65 years and older with non-Hodgkin lymphoma who underwent alloHCT.
A National Cancer Database analysis revealed racial and ethnic disparities in patients with gastric cancer in the use of preoperative chemotherapy and in outcomes.
Survival outcomes may be worse for patients with ALL living in intermediate and high socioeconomically deprived areas as well as for those treated in hospitals with lower volumes of patients.